Tuberculosis (TB), caused by infection with Mycobacterium tuberculosis, is a major cause of
morbidity and mortality worldwide. Efforts to control it are hampered by difficulties with …

There are 9 million cases of active tuberculosis reported annually; however, an estimated
one-third of the world's population is infected with Mycobacterium tuberculosis and remains …

Latent tuberculosis infection (LTBI) is characterised by the presence of immune responses
to previously acquired Mycobacterium tuberculosis infection without clinical evidence of …

The SARS-CoV-2 Omicron variant (B.1.1.529) has multiple spike protein mutations 1 , 2 that
contribute to viral escape from antibody neutralization 3 , 4 , 5 – 6 and reduce vaccine …

Immunological tests provide evidence of latent tuberculosis in one third of the global population,
which corresponds to more than two billion individuals. Latent tuberculosis is defined by …

Radiotherapy is a major part in the treatment of most common cancers, but many patients
experience local recurrence with metastatic disease. In evaluating response biomarkers, we …

… Robert Wilkinson and Robert Davidson had the idea for the study and supervised its design,
execution, and analysis. Martin Llewelyn and Robert Wilkinson … Patel, Robert Wilkinson, and …

The immune reconstitution inflammatory syndrome (IRIS) has emerged as an important
early complication of antiretroviral therapy (ART) in resource-limited settings, especially in …

Tuberculous meningitis causes substantial mortality and morbidity in children and adults.
More research is urgently needed to better understand the pathogenesis of disease and to …

Background Vitamin D was used to treat tuberculosis in the pre-antibiotic era, and its
metabolites induce antimycobacterial immunity in vitro. Clinical trials investigating the effect of …